Δ9-Tetrahydrocannabinol (THC) impairs visual working memory performance: a randomized crossover trial

被引:0
|
作者
Kirsten C. S. Adam
Manoj K. Doss
Elisa Pabon
Edward K. Vogel
Harriet de Wit
机构
[1] University of California San Diego,Department of Psychology
[2] University of California San Diego,Institute for Neural Computation
[3] Johns Hopkins University,Department of Psychiatry and Behavioral Sciences
[4] Johns Hopkins University,Center for Psychedelic and Consciousness Research
[5] University of Chicago,Department of Psychiatry and Behavioral Neuroscience
[6] University of Chicago,Grossman Institute for Neuroscience, Quantitative Biology, and Human Behavior
[7] University of Chicago,Department of Psychology
[8] University of Chicago,Institute for Mind and Biology
来源
Neuropsychopharmacology | 2020年 / 45卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
With the increasing prevalence of legal cannabis use and availability, there is an urgent need to identify cognitive impairments related to its use. It is widely believed that cannabis, or its main psychoactive component Δ9-tetrahydrocannabinol (THC), impairs working memory, i.e., the ability to temporarily hold information in mind. However, our review of the literature yielded surprisingly little empirical support for an effect of THC or cannabis on working memory. We thus conducted a study with three main goals: (1) quantify the effect of THC on visual working memory in a well-powered sample, (2) test the potential role of cognitive effects (mind wandering and metacognition) in disrupting working memory, and (3) demonstrate how insufficient sample size and task duration reduce the likelihood of detecting a drug effect. We conducted two double-blind, randomized crossover experiments in which healthy adults (N = 23, 23) performed a reliable and validated visual working memory task (the “Discrete Whole Report task”, 90 trials) after administration of THC (7.5 and/or 15 mg oral) or placebo. We also assessed self-reported “mind wandering” (Exp 1) and metacognitive accuracy about ongoing task performance (Exp 2). THC impaired working memory performance (d = 0.65), increased mind wandering (Exp 1), and decreased metacognitive accuracy about task performance (Exp 2). Thus, our findings indicate that THC does impair visual working memory, and that this impairment may be related to both increased mind wandering and decreased monitoring of task performance. Finally, we used a down-sampling procedure to illustrate the effects of task length and sample size on power to detect the acute effect of THC on working memory.
引用
收藏
页码:1807 / 1816
页数:9
相关论文
共 50 条
  • [21] Metabolism of (-)-Δ9-Tetrahydrocannabinol (THC) in Chicken and Potential Exposure of THC and Its Metabolites to Humans
    Wang, Ziteng
    Soo, Chock Ying
    Goh, Evelyn Mei Ling
    Moy, Hooi Yan
    Chan, Eric Chun Yong
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [22] Genetic moderation of the effects of cannabis: Catechol-O-methyltransferase (COMT) affects the impact of 9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences
    Tunbridge, Elizabeth M.
    Dunn, Graham
    Murray, Robin M.
    Evans, Nicole
    Lister, Rachel
    Stumpenhorst, Katharina
    Harrison, Paul J.
    Morrison, Paul D.
    Freeman, Daniel
    JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (11) : 1146 - 1151
  • [23] A PROPOSAL FOR THE STANDARDIZATION OF DRUG SCREENING USING BLOOD SAMPLES FOR THE DETECTION OF Δ9-TETRAHYDROCANNABINOL (THC) AND 11-HYDROXY-Δ9-TETRAHYDROCANNABINOL (11-OH-THC)
    Lambert, Graham
    Cullison, Charles
    Sadik, Amina
    JOURNAL OF LEGAL MEDICINE, 2017, 37
  • [24] Assessment of Orally Administered?9-Tetrahydrocannabinol When Coadministered With Cannabidiol on?9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial
    Zamarripa, C. Austin
    Spindle, Tory R.
    Surujunarain, Renuka
    Weerts, Elise M.
    Bansal, Sumit
    Unadkat, Jashvant D.
    Paine, Mary F.
    Vandrey, Ryan
    JAMA NETWORK OPEN, 2023, 6 (02) : e2254752
  • [25] Partial agonist and antagonist effects of Δ9-tetrahydrocannabinol (Δ9THC) in rats
    Paronis, Carol A.
    Thakur, Ganesh A.
    Vemuri, Kiran
    Makriyannis, Alex
    Bergman, Jack
    FASEB JOURNAL, 2007, 21 (05): : A409 - A409
  • [26] An assessment of sex differences in Δ9-tetrahydrocannabinol (THC) taste and place conditioning
    Hempel, Briana J.
    Wakeford, Alison G. P.
    Nelson, Katharine H.
    Clasen, Matthew M.
    Woloshchuk, Claudia J.
    Riley, Anthony L.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2017, 153 : 69 - 75
  • [27] Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review
    Poyatos, Lourdes
    Pilar Perez-Acevedo, Ana
    Papaseit, Esther
    Perez-Mana, Clara
    Martin, Soraya
    Hladun, Olga
    Siles, Adria
    Torrens, Marta
    Paolo Busardo, Francesco
    Farre, Magi
    MEDICINA-LITHUANIA, 2020, 56 (06): : 1 - 28
  • [28] Influence of Δ9-Tetrahydrocannabinol (THC) on Fear Extinction Learning and Spontaneous Recovery
    Hammoud, Mira
    Gorka, Stephanie
    Rabinak, Christine
    Liberzon, Israel
    Maren, Stephen
    Phan, K. Luan
    Milad, Mohammed
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S348 - S348
  • [29] Effects of δ9-tetrahydrocannabinol (THC) on the free choice intake of an opiate in rats
    Wolffgramm, J
    Galli, G
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R92 - R92
  • [30] Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imaging
    Jodi M. Gilman
    William A. Schmitt
    Kevin Potter
    Brian Kendzior
    Gladys N. Pachas
    Sarah Hickey
    Meena Makary
    Marilyn A. Huestis
    A. Eden Evins
    Neuropsychopharmacology, 2022, 47 : 944 - 952